Orbital Therapeutics

BiotechnologySeries ACambridge, USorbitaltx.com

Latest round

Series A

Last raised

Mar 2023

Total raised

$320M

Investors

14

About Orbital Therapeutics

Based in the US, and co-founded by Giuseppe Ciaramella (CEO), Kristina Burow, and Carol Suh, in 2022, Orbital Therapeutics is a biotechnology research company working on the enhancement of global health by unleashing the full potential of RNA-based medicines. The company is working on building a platform that integrates and applies established and emerging technologies across RNA delivery methods excluding RNAi therapeutics, data science, and automation to develop medicines focused in the areas of vaccines, immunomodulation, protein replacement, and regenerative medicine and hence treat human diseases.

Who invested in Orbital Therapeutics

14 investors across 2 rounds

See all investors in Orbital Therapeutics

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Series A

    Mar 9, 2023

    Amount

    $270M

    Investors

    Locked

  2. Seed

    Aug 16, 2022

    Amount

    $50M

    Investors

    Locked

Questions about Orbital Therapeutics

Who invested in Orbital Therapeutics?

Orbital Therapeutics has 14 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has Orbital Therapeutics raised?

Orbital Therapeutics has raised 2 venture rounds. Sign up free to see how much each round raised and the total.

When did Orbital Therapeutics last raise money?

Orbital Therapeutics's most recent round on record is a Series A, in Mar 2023.

What does Orbital Therapeutics do?

Based in the US, and co-founded by Giuseppe Ciaramella (CEO), Kristina Burow, and Carol Suh, in 2022, Orbital Therapeutics is a biotechnology research company working on the enhancement of global health by unleashing the full potential of RNA-based medicines.

Where is Orbital Therapeutics headquartered?

Orbital Therapeutics is headquartered in Cambridge, US.

Which VCs invest in companies like Orbital Therapeutics?

Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Orbital Therapeutics's stage. Their profiles are linked below.

Raising like Orbital Therapeutics? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.